Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
CELL GROWTH AND DEVELOPMENT

Structure and Specificity of GATA Proteins in Th2 Development

Sheila Ranganath, Kenneth M. Murphy
Sheila Ranganath
Department of Pathology and Center for Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth M. Murphy
Department of Pathology and Center for Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/MCB.21.8.2716-2725.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    GATA-3 but not c-Maf or JunB induces IL-4 expression in Stat6-deficient T cells. (A) Schematic of GFP-RV-based retroviral expression constructs containing GATA-3 (GATA3-RV), c-Maf (cmaf-RV), or JunB (JunB-RV). (B) Induction of IL-4 by GATA-3 but not by c-Maf or JunB in Stat6-deficient T cells. Activated Stat6-deficient or wild-type DO11.10 splenocytes developed under Th2 conditions were transduced with the indicated retrovirus as described (39). Cells were sorted 7 days after the first activation, restimulated with ovalbumin (0.5 mg/ml) and irradiated BALB/c splenocytes (2.5 × 106 cells, 2,000 rad) for 1 week under the initial conditions, then harvested (day 14), and restimulated. Supernatants were collected after 48 h (day 16) for IL-4 ELISA analysis. Data bars represent the average of four independent cytokine readings for each point, and error bars show the standard deviation. (C) c-Maf and JunB fail to suppress production of IFN-γ in Stat6-deficient T cells. Supernatants described in for panel B were subjected to quantitation of IFN-γ levels by ELISA as described (14). Data are presented as in panel B. (D) Expression of murine stem cell virus (MSCV) long terminal repeat (LTR)-driven GATA-3, c-Maf, and JunB. 293 cells were transiently transfected with 20 μg of GATA3-RV, cmaf-RV, and JunB-RV using Superfect (Quiagen). After 48 h, cells lysates were electrophoresed by SDS–12% PAGE, transferred to nitrocellulose, and analyzed by Western analysis. GATA-3 was detected using antibody HG3-31 (Santa Cruz), c-Maf was detected using M173 (Santa Cruz), JunB was detected using N17 (Santa Cruz), and Stat1 was detected using E23 (Santa Cruz).

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Heterologous GATA factors induce Th2 development. (A) Schematic of constructs driving the expression of control vector (GFP-RV), GATA-1 (G1-RV), GATA2 (G2-RV), GATA-3 (G3-RV), and GATA-4 (G4-RV). IL-4 (B and E) and IL-5 (C and F) induction by GATA-1, GATA-2, GATA-3, and GATA-4 in developing DO11.10 Th1 cells and Stat6-deficient T cells. Activated splenocytes were developed under the indicated conditions and transduced with the indicated retroviral expression constructs 36 h postactivation. Cells were sorted 7 days after the first activation for expression of GFP and murine CD4 to greater than 95% puarity, restimulated with ovalbumin protein (0.5 mg/ml) and irradiated BALB/c splenocytes (2.5 × 106 cells, 2,000 rad) for 1 week under the initial conditions, harvested on day 14, and restimulated for cytokine analysis. Supernatants were collected after 48 h (day 16) and subjected to IL-4 and IL-5 ELISA analysis. Data are presented as in Fig. 1B. (D and G) GATA-1, GATA-2, GATA-3, and GATA-4 repress IFN-γ production by developing wild-type Th1 cells (D) and Stat6-deficient cells (G). The supernatants collected from the cells described above were quantified for their levels of IFN-γ by ELISA. Data are presented as in Fig. 1B.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Repression of IL-12Rβ2 expression by heterologous GATA factors. Northern analysis of IL-12Rβ2 mRNA in cells transduced with GATA-1, GATA-2, GATA-3, and GATA-4. Stat6-deficient lymphocytes transduced with GATA proteins (as described in the legend to Fig. 2E) were restimulated and expanded for subsequent Northern analysis. Cells were harvested on day 28 and restimulated with PMA (50 ng/ml) and ionomycin (1 M) for 6 h prior to RNA isolation; 10 μg of total RNA was subjected to electrophoresis on a 1.1% agarose gel, transferred to Zeta-probe membrane, and probed sequentially with IL-12Rβ2 and GAPDH probes as described (43).

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Heterologous GATA family proteins induce endogenous GATA-3 expression. (A) Northern analysis of retroviral and endogenous mRNA in cells transduced with GATA-1, GATA-2, GATA-3, and GATA-4. The cells described in the legend to Fig. 2E were analyzed for expression of GATA-1, GATA-2, GATA-3, and GATA-4 as described for Fig. 3. Open triangles indicate the predicted retroviral GATA mRNA, and solid triangles indicate the predicted endogenous GATA mRNA. (B) Western analysis of GATA-3 protein levels. Cells were harvested on day 28 and stimulated with PMA (50 ng/ml) and ionomycin (1 μM) for 16 h. Cytoplasmic and nuclear proteins were extracted as described in Materials and Methods, then electrophoresed through an SDS–12% PAGE gel, and transferred to nitrocellulose. GATA-3 was detected using antibody HG3-31, and Stat1 was detected using antibody E23 (Santa Cruz) as a normalization control.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Distinct domains couple GATA-3 to IL-4 activation and IFN-γ inhibition. (A) Schematic of GATA-3 mutations, illustrating the four described functional domains of GATA-3 and the amino acids (aa) deleted from each specific expression construct: ΔTA1-RV, deletion of GATA-3 residues 29 to 128; ΔTA2-RV, deletion of GATA-3 132 to 214; ΔNf, deletion of GATA-3 249 to 308, encompassing the entire N-terminal zinc finger; and ΔCf, deletion of GATA-3 309 to 328, a portion of the C-terminal zinc finger region. (B) QT6 cells were transiently transfected with the indicated GATA-3 expression constructs, and nuclear extracts were prepared after 48 h. Nuclear extracts were electrophoresed by SDS–12% PAGE, transferred to nitrocellulose, and probed for GATA-3 expression (upper panel). Nuclear extracts were incubated in 10-μl reactions with the GATA-3 probe for 30 min and resolved by 6% polyacrylamide electrophoresis at room temperature. The solid triangle indicates the probe-bound GATA complex. (C and E) Mutant GATA proteins fail to activate IL-4 in developing Th1 and Stat6-deficient DO11.10 cells. Data are presented as in Fig. 1B. (D and F) Mutant GATA proteins differentially repress IFN-γ production in developing Th1 (D) and Stat6-deficient (F) T cells. Data are presented as in Fig. 1B. L.D., limit of detection.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Structural requirements for GATA-3 autoactivation. Cells described in the legends to Fig. 5D and 5E were harvested on day 28, and total RNA was isolated; 10 μg of total RNA was subjected to electrophoresis on a 1.1% agarose gel, transferred to Zeta-probe membrane, and probed sequentially with GATA-3 (35) and GAPDH (43) probes as described. The open triangle indicates the predicted retroviral GATA-3 mRNA, and the solid triangle indicates the predicted endogenous GATA-3 mRNA.

PreviousNext
Back to top
Download PDF
Citation Tools
Structure and Specificity of GATA Proteins in Th2 Development
Sheila Ranganath, Kenneth M. Murphy
Molecular and Cellular Biology Apr 2001, 21 (8) 2716-2725; DOI: 10.1128/MCB.21.8.2716-2725.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Structure and Specificity of GATA Proteins in Th2 Development
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Structure and Specificity of GATA Proteins in Th2 Development
Sheila Ranganath, Kenneth M. Murphy
Molecular and Cellular Biology Apr 2001, 21 (8) 2716-2725; DOI: 10.1128/MCB.21.8.2716-2725.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

DNA-Binding Proteins
Th2 Cells
Trans-Activators

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549